We first reanalyzed our previously published single-cell RNA sequencing datasets [19, 20], including a cohort of ibrutinib-sensitive, ibrutinib-resistant, and dual ibrutinib-/CAR T-resistant patient specimens, to interrogate the correlation between the MCL1 expression and therapeutic resistance in MCL. The gene discussed is MCL1; the disease is mantle cell lymphoma.